Point72 Middle East FZE’s Pulmonx LUNG Stock Holding History

Point72 Middle East FZE’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,717	Closed	-$14.5K	–	1961
2022 Q4	$14.5K	Buy	+1,717	New	+$16.3K	﹤0.01%	1686

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Middle East FZE's LUNG Position: Q1 2023 in Review

Point72 Middle East FZE sold out of Pulmonx (LUNG) in Q1 2023, closing a stake of 1,717 shares — an estimated $14.5K sold.

Point72 Middle East FZE first reported a position in LUNG in Q4 2022 and held it in 1 quarter. The position peaked at $14.5K in Q4 2022. 102 funds tracked by Wall St. Rank hold LUNG as of Q1 2023.

Point72 Middle East FZE reported no remaining Pulmonx position as of Q1 2023 after selling out during the quarter.
Point72 Middle East FZE sold 1,717 Pulmonx shares in Q1 2023, an estimated $14.5K.
Point72 Middle East FZE first reported a position in Pulmonx in Q4 2022 and held it in 1 quarter.
Point72 Middle East FZE's Pulmonx position peaked at $14.5K in Q4 2022.
102 funds tracked by Wall St. Rank held Pulmonx as of Q1 2023.

Based on Point72 Middle East FZE's 13F filing for Q1 2023, filed 15 May 2023.